Novo Nordisk A/S Common Stock (NVO)

EBITDA Margin

54.91%

TTM · Period ending:

NVO logo

NVO EBITDA Margin

Latest reported54.91%
NVO TTM EBITDA Margin (17.72% → 54.91%)
High-resolution chart · PNG

NVO ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
42.0619%
43.5214%
43.9352%
47.4154%
26.0493%
21.1277%
17.6353%
22.1562%
19.0191%
17.0931%
15.1455%
20.7391%
17.5314%
15.4202%
12.5654%
20.5614%
17.2724%
13.8701%
12.7514%
15.5593%
12.7527%
13.1733%
12.7631%
14.8793%
15.8423%
14.9209%
13.2827%
20.8408%
19.4532%
16.9478%
13.8493%
17.1051%
12.8082%
11.2273%
11.5209%
23.2724%
22.0456%
17.7838%
14.5705%
21.2524%
18.0301%
15.9738%
12.5849%
19.3612%
16.4734%
13.4525%
13.8529%
34.0471%
29.8318%
25.7227%
15.1345%
17.0119%
16.2338%
12.5625%
13.2629%
25.3114%
21.0078%
19.9738%
16.1143%
18.2829%
17.7189%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.